H.R. 5020: Synthetic Drug Awareness Act of 2016

Introduced:

Apr 21, 2016

Status:

Referred to Committee on Apr 21, 2016

This bill was assigned to a congressional committee on April 21, 2016, which will consider it before possibly sending it on to the House or Senate as a whole.

Sponsor:

Hakeem Jeffries

Representative for New York's 8th congressional district

Democrat

Text:

Read Text »
Last Updated: Apr 21, 2016
Length: 2 pages

Prognosis:

2% chance of being enacted (details)

About the bill

Full Title

To require the Surgeon General of the Public Health Service to submit to Congress a report on the effects on public health of the increased rate of use of synthetic drugs.

The bill’s titles are written by its sponsor.

Read CRS Summary >

History

Apr 21, 2016
 
Introduced

This is the first step in the legislative process.

 
Reported by Committee

 
Passed House

 
Passed Senate

 
Signed by the President

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: